Purpose

DISSECT-N is a post-market registry designed to assess real-world safety and effectiveness of Valiant Navion Thoracic Stent Graft System in the treatment of thoracic aortic dissections in real world practice.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Subject is ≥18 years old - Subject was treated in the last 7 days, or is intended to be treated, with the Valiant Navion Thoracic Stent Graft System for a dissection in the thoracic aorta - Subject is willing to comply with standard of care clinical follow-up - Subject or legal representative has consented for study participation and signed the approved Informed Consent

Exclusion Criteria

  • Subject is participating in an investigational drug or device study which may bias or interfere with the endpoints and follow-up of this study. - Subject is pregnant (not an exclusion if allowed per local regulatory requirements, pregnancy test to be performed where required)

Study Design

Phase
Study Type
Observational [Patient Registry]
Observational Model
Cohort
Time Perspective
Prospective

Recruiting Locations

University of Alabama at Birmingham Hospital
Birmingham, Alabama 35233
Contact:
Adam Beck, MD

More Details

Status
Recruiting
Sponsor
Medtronic Endovascular

Study Contact

Jennifer L Heim
763-526-3553
jennifer.l.heim@medtronic.com

Detailed Description

DISSECT-N is a prospective, observational, global, multi-center, post-market registry designed to assess real-world safety and effectiveness of Valiant Navion Thoracic Stent Graft System in the treatment of thoracic aortic dissections in real world practice.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.